In the specialized field of biochemical research, the study of protein fragments serves as a cornerstone for understanding cellular signaling and structural biology. Among these, Amyloid β peptide 1-40 stands out as a critical subject of investigation. As someone deeply involv Beta-Amyloid (1-40), also known as Abeta (1-40),is a 40-amino-acid peptidederived from the human amyloid precursor protein (APP).Read more ed in th Beta-Amyloid Peptide (1-40), mouse, rat e procurement and analysis of research-grade biochemicals, I have found that distinguishing the nuances of these sequences is essential for high-fidelity experimental design.
Structural Profile and Composition
At its core, Amyloid β (Aβ) is a 40-residue peptide derived from the proteolytic cleavage of the amyloid precursor protein (APP). When we examine the Human Amyloid Beta Peptide 1-40 Monomers, we are looking at a sequence that acts as a 40-amino-acid peptide, typically synthesized to mirror the endogenous human form.
The molecular weigh Amyloid Beta-Peptide (1-40), Human t of Amyloid Beta-Peptide (1-40) (human) this substance is approximately 4329.9 g/mol. Researchers often source beta-Amyloid (1-40), Ultra Pure, TFA to ensure that experimental variables—such as aggregation kinetics—are not skewed by impurities. This specific form is widely recognized because it is a major constituent of am Human Amyloid Beta Peptide 1-40 Monomers (SPR-530) yloid plaques often discussed in the context of neurodegenerative research.
Comparative Analysis: Human vs. Rodent Models
One of the most frequent questions in laboratory settings involves the divergence between species. While the human variant is the primary focus for many, the amino acids 1 to 40 fragment of mouse and rat beta-amyloid presents a unique alternative. This version differs from the human sequence by three specific amino acid residues: Arg5, Tyr10, and His13. Understanding these differences is vital when conducting cross-species comparative studies, as these residues can influence how the molecule interacts with its environment.
Experimental Considerations and Variants
During my own procurement processes, I have encountered various specialized iterations, such as:
* [Gln22]-beta-Amyloid (1-40): A modified sequence used to study specific structural mutations.
* Scrambled-beta-Amyloid (1-40): Often utilized as a negative control to verify that observed effects are sequence-specific.
* Isotopically labeled (N15) variants: These are invaluable for NMR structural studies, providing a clear window into the conformational changes of the peptide.
It is important to Amyloid-Beta 1-40 Wild type (1.0 mg) Human, Recombinant note that β-Amyloid (1-40) TFA is a standard laboratory product for research use only. It is not for personal consumption, as it is biologically inert in a supplemental context and potentially dangerous if handled incorrectly.
Functional Insights
The functional range of this peptide is broad. For instance, Amyloid beta peptide 1-40 enhances the action of Toll-like receptor-2 and -4 agonists, illustrating its active role in inflammatory signaling pathways. Furthermore, when comparing Amyloid Beta and its longer counterpart (1-42), researchers often look at the Amyloid beta 40/42 ratio to assess aggregation states in liquid chromatography or ELISA assays.
Whether you are using Recombinant human Amyloid-Beta 1-40 for crystallization or standard peptide preparations for binding assays, the key is the purity of the sample. In my experience, high-quality material is the only way to ensure that the Amyloid species behaves predictably in a controlled environment.
Final Thoughts on Research Integrity
When selecting a supplier, always verify the HPLC purity and the specific trifluoroacetic acid (TFA) salt content. Since Amyloid β peptide 1-40 is a peptide found in plaques in the brains of patients with Alzheimer's disease, the scientific community relies on the consistency of these synthetic fragments to model complex biological interactions. By focusing Beta-Amyloid peptides(A-beta), the major constituent ofamyloidplaques in the brains of Alzheimer's patients, is thought to be a primary contributor to Read more on high-purity, well-documented reagents, we contribute to a more robust and verifiable body of research, ensuring that our data on beta-amyloid remains precise and reproducible.